These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 35988428)

  • 1. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
    Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
    Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
    Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
    Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis
    Yan J; Li Z; Liang Y; Yang C; Ou W; Mo H; Tang M; Chen D; Zhong C; Que D; Feng L; Xiao H; Song X; Yang P
    Food Funct; 2023 Nov; 14(22):10052-10068. PubMed ID: 37861458
    [No Abstract]   [Full Text] [Related]  

  • 4. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucoxanthin Attenuates Myocardial Ischemia/Reperfusion-Induced Injury via AMPK/GSK-3β/Nrf2 Axis.
    Zhang Q; Jin A; Cheng H; Li S; Li W
    Chem Biol Drug Des; 2024 Sep; 104(3):e14621. PubMed ID: 39251393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
    Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
    Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway.
    Duan J; Guan Y; Mu F; Guo C; Zhang E; Yin Y; Wei G; Zhu Y; Cui J; Cao J; Weng Y; Wang Y; Xi M; Wen A
    Sci Rep; 2017 Jan; 7():41491. PubMed ID: 28128361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling.
    Lu H; Xiao H; Dai M; Xue Y; Zhao R
    Pharm Biol; 2022 Dec; 60(1):38-45. PubMed ID: 34860639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKK2 alleviates myocardial ischemia/reperfusion injury by inhibiting oxidative stress and inflammation via the action on the AMPK-AKT-GSK-3β/Nrf2 signaling cascade.
    Li C; Hao J; Qiu H; Xin H
    Inflamm Res; 2023 Jul; 72(7):1409-1425. PubMed ID: 37338678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSKIP protects cardiomyocytes from hypoxia/reoxygenation-induced injury by enhancing Nrf2 activation via GSK-3β inhibition.
    Yan L; Cheng G; Yang G
    Biochem Biophys Res Commun; 2020 Oct; 532(1):68-75. PubMed ID: 32828530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway.
    Yang T; Liu H; Yang C; Mo H; Wang X; Song X; Jiang L; Deng P; Chen R; Wu P; Chen A; Yan J
    Drug Des Devel Ther; 2023; 17():2495-2511. PubMed ID: 37637264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
    Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
    J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
    Deng L; Chen H; Wei N; Zhang Z; Wang G
    Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
    Mei SL; Xia ZY; Qiu Z; Jia YF; Zhou JJ; Zhou B
    Chin J Integr Med; 2022 Nov; 28(11):983-991. PubMed ID: 35997859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TNFAIP1 ameliorates the oxidative stress and inflammatory injury in myocardial ischemia/reperfusion injury through modulation of Akt/GSK-3β/Nrf2 pathway.
    Wen L; Yang QH; Ma XL; Li T; Xiao S; Sun CF
    Int Immunopharmacol; 2021 Oct; 99():107993. PubMed ID: 34330059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.
    Yu P; Zhang J; Ding Y; Chen D; Sun H; Yuan F; Li S; Li X; Yang P; Fu L; Yu S; Zhang J
    Hum Cell; 2022 May; 35(3):836-848. PubMed ID: 35212945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
    Li F; Hu Z; Huang Y; Zhan H
    J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and possible mechanism of the ferroptosis-related SLC7A11/GSH/GPX4 pathway in myocardial ischemia-reperfusion injury.
    Chen B; Fan P; Song X; Duan M
    BMC Cardiovasc Disord; 2024 Oct; 24(1):531. PubMed ID: 39354361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.